Proteasome inhibitors induce apoptosis in growth hormone- and prolactin-secreting rat pituitary tumor cells

Journal of Endocrinology

Volumn 174, Issue 3, 2002, Pages 379-386

  Yu, R ^a   Ren, S G ^a   Melmed, S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CALPASTATIN; CASPASE; CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 8; DNA; DOPAMINE RECEPTOR STIMULATING AGENT; FULVESTRANT; LACTACYSTIN; LEPTIN; POTASSIUM CHANNEL BLOCKING AGENT; PROLACTIN; PROTEASOME INHIBITOR; SOMATOSTATIN DERIVATIVE; TAMOXIFEN; TETRYLAMMONIUM CHLORIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASSAY; CANCER CELL; CANCER INHIBITION; CELL CYCLE G2 PHASE; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; DRUG RESISTANCE; ENZYME ACTIVATION; ENZYME SUBSTRATE; HYPOPHYSIS CELL; HYPOPHYSIS TUMOR; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTIN SECRETING CELL; RAT; WESTERN BLOTTING;

ACETYLCYSTEINE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASES; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; GROWTH HORMONE; IN SITU NICK-END LABELING; LEUPEPTINS; MULTIENZYME COMPLEXES; PITUITARY GLAND, ANTERIOR; PITUITARY NEOPLASMS; PROLACTINOMA; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; TUMOR CELLS, CULTURED;

EID: 0036739427     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1740379     Document Type: Article

References (26)

1. Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S & Elliott PJ 1999 Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Research 59 2615-2622.
2. Akita S, Webster J, Ren SG, Takino H, Said J, Zand O & Melmed S 1995 Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. Journal of Clinical Investigation 95 1288-1298.
3. Cryns V & Yuan J 1998 Proteases to die for. Genes and Development 12 1551-1570.
4. Cusack JC Jr, Liu R, Houston M, Abendroth K, Elliott PJ, Adams J & Baldwin AS Jr 2001 Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. Cancer Research 61 3535-3540.
5. Drexler HC 1997 Activation of the cell death program by inhibition of proteasome function. PNAS 94 855-860.
6. Drexler HC, Risau W & Konerding MA 2000 Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells. FASEB Journal 14 65-77.
7. Heaney AP, Fernando M & Melmed S 2001 Functional role of estrogen in pituitary tumor pathogenesis. Journal of Clinical Investigation 109 277-283.
8. Herrmann JL, Briones F Jr, Brisbay S, Logothetis CJ & McDonnell TJ 1998 Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53. Oncogene 17 2889-2899.
9. Hershko A 1999 Mechanisms and regulation of the degradation of cyclin B. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 354 1571-1575.
10. Jin L, Zhang S, Burguera BG, Couce ME, Osamura RY, Kulig E & Lloyd RV 2000 Leptin and leptin receptor expression in rat and mouse pituitary cells. Endocrinology 141 333-339.
11. Lee SY, Ahn BT, Baik SH & Lee BL 1998 Tamoxifen inhibits GH3 cell growth in culture via enhancement of apoptosis. Neurosurgery 43 116-123.
12. Lopes UG, Erhardt P, Yao K & Cooper GM 1997 p53-dependent induction of apoptosis by proteasome inhibitors. Journal of Biological Chemistry 272 12893-12896.
13. McDade TP, Perugini RA, Vittimberga FJ Jr & Callery MP 1999 Ubiquitin-proteasome inhibition enhances apoptosis of human pancreatic cancer cells. Surgery 126 371-377.
14. Pickart CM 2000 Ubiquitin in chains. Trends in Biochemical Sciences 25 544-548.
15. Ren SG & Braunstein GD 1990 Progesterone and human chorionic gonadotropin do not stimulate placental proteins 12 and 14 or prolactin production by human decidual tissue in vitro. Journal of Clinical Endocrinology and Metabolism 70 983-989.
16. Russo SM, Tepper JE, Baldwin AS Jr, Liu R, Adams J, Elliott P & Cusack JC Jr 2001 Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. International Journal of Radiation Oncology, Biology, Physics 50 183-193.
17. Shimon I & Melmed S 1998 Management of pituitary tumors. Annals of Internal Medicine 129 472-483.
18. Soligo D, Servida F, Delia D, Fontanella E, Lamorte G, Caneva L, Fumiatti R & Lambertenghi Deliliers G 2000 The apopitogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSI. British Journal of Haematology 113 126-135.
19. Sun J, Nam S, Lee CS, Li B, Coppola D, Hamilton AD, Dou QP & Sebti SM 2001 CEP1612, a dipeptidyl proteasome inhibitor, induces p21 WAF1 and p27 KIP1 expression and apoptosis and inhibits the growth of the human lung adenocarcinoma A-549 in nude mice. Cancer Research 61 1280-1284.
20. Suzuki Y, Nakabayashi Y & Takahashi R 2001 Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. PNAS 98 8662-8667.
21. Thornberry NA & Lazebnik Y 1998 Caspases: enemies within. Science 281 1312-1316.
22. Vaur S, Bresson-Bepoldin L, Dufy B, Tuffet S & Dufy-Barbe L 1998 Potassium channel inhibition reduces cell proliferation in the GH3 pituitary cell line. Journal of Cellular Physiology 177 402-410.
23. Voges D, Zwickl P & Baumeister W 1999 The 26S proteasome: a molecular machine designed for controlled proteolysis. Annual Review of Biochemistry 68 1015-1068.
24. Yu R, Ren S-G, Horwitz GA, Wang Z & Melmed S 2000a Pituitary tumor transforming gene (PTTG) regulates placental JEG-3 cell division and survival: evidence from live cell imaging. Molecular Endocrinology 14 1137-1146.
25. Yu R, Heaney AP, Lu W, Chen J & Melmed S 2000b Pituitary tumor transforming gene causes aneuploidy and p53-dependent and p53-independent apoptosis. Journal of Biological Chemistry 275 36502-36505.
26. Zou H, McGarry TJ, Bernal T & Kirschner MW 1999 Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285 418-422.